Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel,
Abstract With the development of new cancer therapies, systemic toxicity profile and effects on survival achieved an important improvement. However, a constellation of toxicities has emerged, even more remarkably, cutaneous adverse events. This report, developed by a board of Brazilian experts in oncodermatology, aims to establish a guideline for the dermatological care of oncologic patients. When possible, evidence-based recommendations were made, but in many cases, when strong evidence was not available, a consensus was reached, based on some data supporting therapies combined with personal experiences.
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Digital revista |
| Language: | English |
| Published: |
Sociedade Brasileira de Dermatologia
2020
|
| Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962020000200221 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|